title: Valsartan inhibits transient receptor potential canonical-3 channel in canine atrial fibrillation.
authors.affiliation: Department of Cardiology, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, Heilongjiang Province, China; Key Laboratory of Cardiac Diseases and Heart Failure, Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
authors.forename: Jing
authors.initials: J
authors.lastname: Zhao
authors.forename: Xiaoyu
authors.initials: X
authors.lastname: Wang
authors.forename: Pengzhou
authors.initials: P
authors.lastname: Hang
authors.forename: Fengxiang
authors.initials: F
authors.lastname: Yun
authors.forename: Hongwei
authors.initials: H
authors.lastname: Zhao
authors.forename: Wei
authors.initials: W
authors.lastname: Xu
authors.forename: Danghui
authors.initials: D
authors.lastname: Sun
authors.forename: Li
authors.initials: L
authors.lastname: Sun
authors.forename: Yue
authors.initials: Y
authors.lastname: Li
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology* / Q000627:therapeutic use*; D000818:Animals; D001281:Atrial Fibrillation / Q000188:drug therapy*; D004195:Disease Models, Animal; D004285:Dogs; D050052:TRPC Cation Channels / Q000037:antagonists & inhibitors*; D013777:Tetrazoles / Q000494:pharmacology* / Q000627:therapeutic use*; D014633:Valine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000068756:Valsartan
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D050052:TRPC Cation Channels; C104603:TRPC3 cation channel; D013777:Tetrazoles; D000068756:Valsartan; D014633:Valine
keywords: Atrial fibrillation; Transient receptor potential canonical-3; Valsartan; Western blotting